Nephros (NEPH) Change in Accured Expenses (2010 - 2026)

Nephros' Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$791000.0 for Q1 2026.

• On a quarterly basis, Change in Accured Expenses fell 825.69% year-over-year to -$791000.0 in Q1 2026; TTM through Mar 2026 was $124000.0, a 52.85% decrease from a year earlier, with the FY2025 full-year figure at $1.0 million, up 553.1% from the prior year.
• Change in Accured Expenses eased to -$791000.0 in Q1 2026 per NEPH's latest filing, from $367000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $380000.0 in Q3 2025 and bottomed at -$791000.0 in Q1 2026.
• The 5-year median for Change in Accured Expenses is $88000.0 (2022), against an average of $21352.9.
• Across the five-year window, Change in Accured Expenses surged 663.64% in 2025 and plunged 825.69% in 2026, its largest moves.
• Year by year, Change in Accured Expenses stood at $24000.0 in 2022, then surged by 237.5% to $81000.0 in 2023, then jumped by 201.23% to $244000.0 in 2024, then jumped by 50.41% to $367000.0 in 2025, then tumbled by 315.53% to -$791000.0 in 2026.
• Per Business Quant, the three latest NEPH Change in Accured Expenses figures stand at -$791000.0 (Q1 2026), $367000.0 (Q4 2025), and $380000.0 (Q3 2025).